(Q34993711)

5 August 2017

1 reference

title

Nonalcoholic steatohepatitis: what we know in the new millennium (English)

1 reference

5 August 2017

0 references

Stephen A Harrison

1

1 reference

5 August 2017

Shailesh Kadakia

series ordinal

2

1 reference

5 August 2017

Kevin A Lang

series ordinal

3

1 reference

5 August 2017

Steven Schenker

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

The American Journal of Gastroenterology

5 August 2017

published in

1 reference

5 August 2017

volume

97

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

2714-2724

1 reference

Post-jejunoileal-bypass Hepatic Disease: Its Similarity to Alcoholic Hepatic Disease

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic steatohepatitis: a study of 49 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Animal models of steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

A resistance movement in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Serum leptin levels in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Signalling by CD95 and TNF receptors: not only life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Fatty infiltration of liver in hyperlipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Fatty liver hepatitis and cirrhosis in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic steatohepatitis: An expanded clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Recurrence of nonalcoholic steatohepatitis following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

NAFLD and NASH: important diseases before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Hepatic mitochondrial energy production in rats with chronic iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Targeting dexamethasone to Kupffer cells: Effects on liver inflammation and fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Nonalcoholic steatohepatitis in obesity: a reversible condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.07069.X

10.1111/J.1572-0241.2002.07069.X

21 January 2018

Identifiers

DOI

0 references

1 reference